| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.084 | 0.07 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.095 | 0.08 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.066 | 0.1 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.052 | 0.2 |